UK opens first clinic devoted to prion disease:
This article was originally published in Clinica
Executive Summary
The UK's first clinic devoted specifically to the diagnosis and treatment of prion diseases has been opened in London. The centre, headed by John Collinge of St Mary's Hospital, will work in close collaboration with the prion unit of the Medical Research Council, based at Imperial College London, which has launched a "major" research programme in this area. During his presentation of the centre at the World Congress of Neurology, held last week in London, Professor Collinge announced that the new clinic will offer a full range of diagnostic facilities including molecular genetic analysis and tonsil biopsy. Brain imaging and other tests will be provided to outpatients, with a neurological ward available for further investigations.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.